Invesco’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.8K Sell
442,268
-22,700
-5% -$6.34K ﹤0.01% 3769
2026
Q1
$153K Sell
464,968
-13,941
-3% -$21.9K ﹤0.01% 3557
2025
Q4
$1.48M Buy
478,909
+126,823
+36% +$362K ﹤0.01% 2742
2025
Q3
$926K Buy
352,086
+112,841
+47% +$249K ﹤0.01% 2972
2025
Q2
$294K Buy
239,245
+195,548
+448% +$213K ﹤0.01% 3368
2025
Q1
$48.1K Buy
+43,697
New +$50.5K ﹤0.01% 3703
2023
Q2
Sell
-25,420
Closed -$32K 3887
2023
Q1
$32K Sell
25,420
-32,427
-56% -$62.1K ﹤0.01% 3786
2022
Q4
$126K Sell
57,847
-918,152
-94% -$7.56M ﹤0.01% 3788
2022
Q3
$11.7M Buy
975,999
+916,979
+1,554% +$11.4M ﹤0.01% 1689
2022
Q2
$494K Buy
59,020
+9,251
+19% +$71.7K ﹤0.01% 3334
2022
Q1
$432K Buy
49,769
+2,732
+6% +$26.3K ﹤0.01% 3470
2021
Q4
$532K Sell
47,037
-5,365
-10% -$63.7K ﹤0.01% 3366
2021
Q3
$659K Buy
52,402
+3,321
+7% +$30.6K ﹤0.01% 3300
2021
Q2
$398K Buy
49,081
+10,145
+26% +$88K ﹤0.01% 3516
2021
Q1
$360K Buy
38,936
+27,307
+235% +$275K ﹤0.01% 3475
2020
Q4
$112K Buy
+11,629
New +$115K ﹤0.01% 3626

Other funds holding GOSS

Invesco's GOSS Position: Q2 2026 in Review

Invesco reduced its Gossamer Bio (GOSS) stake by 4.9% in Q2 2026, selling an estimated $6.34K and leaving 442,268 shares worth $72.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3769.

Invesco first reported a position in GOSS in Q4 2020 and has held it in 16 quarters since. The position peaked at $11.7M in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Invesco held 442,268 shares of Gossamer Bio worth $72.8K as of Q2 2026.
  • Invesco sold 22,700 Gossamer Bio shares in Q2 2026, an estimated $6.34K.
  • Gossamer Bio made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3769 holding.
  • Invesco first reported a position in Gossamer Bio in Q4 2020 and has held it in 16 quarters since.
  • Invesco's Gossamer Bio position peaked at $11.7M in Q3 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.